Status:
UNKNOWN
CTHRC1: A Biomarker for Evaluation of Rheumatoid Arthritis Disease Activity
Lead Sponsor:
Assiut University
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18-75 years
Brief Summary
The purpose of the study is to determine whether plasma levels of the collagen triple helix repeat containing (CTHRC1) protein can serve as a blood-based biomarker for diagnosis of rheumatoid arthriti...
Detailed Description
Rheumatoid arthritis (RA) is a chronic, progressive, autoimmune disease of synovial joints. Characterized by periods of flares with high disease activity involving both a systemic immune response and ...
Eligibility Criteria
Inclusion
- patients diagnosed as RA
- age more than 18 years
Exclusion
- other rheumatological diseases Malignancies Hepatic diseases
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04415502
Start Date
October 1 2020
End Date
May 1 2021
Last Update
June 4 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.